Margaret Dalesandro - 01 Sep 2021 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Director
Signature
/s/ Margaret Dalesandro, Ph.D.
Issuer symbol
N/A
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 16:08:35 UTC
Previous filing
25 Aug 2021
Next filing
16 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +42,000 $0.000000 $42,000 01 Sep 2021 Common Stock 42,000 $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option shall vest on September 1, 2022, and 1/36th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.